Owens & Minor (NYSE:OMI) Updates FY 2025 Earnings Guidance

Owens & Minor (NYSE:OMI) updated its FY 2025 earnings guidance on Friday. The company provided earnings per share guidance of 1.600-1.850 for the period, compared to the consensus earnings per share estimate of 1.790. The company issued revenue guidance of $10.9 billion-$11.2 billion, compared to the consensus revenue estimate of $11.0 billion. Owens & Minor also updated its FY25 guidance to $1.60-1.85 EPS.

Wall Street Analyst Weigh In

A number of research analysts have commented on the company. UBS Group decreased their price objective on Owens & Minor from $25.00 to $13.00 and set a “buy” rating on the stock in a research report on Thursday, February 13th. Citigroup decreased their price objective on Owens & Minor from $21.00 to $18.50 and set a “buy” rating on the stock in a research report on Tuesday, November 5th. Barclays reduced their price target on Owens & Minor from $18.00 to $14.00 and set an “equal weight” rating on the stock in a research report on Tuesday, November 5th. Finally, Robert W. Baird reduced their price target on Owens & Minor from $14.00 to $10.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 25th. Two analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $14.92.

Owens & Minor Stock Up 38.7 %

NYSE:OMI opened at $9.56 on Friday. Owens & Minor has a 12-month low of $6.07 and a 12-month high of $28.35. The company has a quick ratio of 0.45, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The firm has a market capitalization of $736.78 million, a P/E ratio of -14.70, a P/E/G ratio of 0.20 and a beta of 0.48. The stock’s fifty day simple moving average is $11.51 and its 200-day simple moving average is $13.24.

Owens & Minor (NYSE:OMI) last posted its earnings results on Friday, February 28th. The company reported $0.55 earnings per share for the quarter, topping the consensus estimate of $0.53 by $0.02. The firm had revenue of $2.70 billion for the quarter, compared to analyst estimates of $2.68 billion. Owens & Minor had a positive return on equity of 14.60% and a negative net margin of 0.46%. The company’s revenue for the quarter was up 1.5% on a year-over-year basis. During the same period in the previous year, the company posted $0.69 earnings per share. Equities research analysts expect that Owens & Minor will post 1.51 earnings per share for the current year.

Owens & Minor declared that its board has authorized a stock buyback program on Friday, February 28th that allows the company to buyback $100.00 million in outstanding shares. This buyback authorization allows the company to purchase up to 13.6% of its stock through open market purchases. Stock buyback programs are typically an indication that the company’s management believes its stock is undervalued.

Owens & Minor Company Profile

Owens & Minor, Inc is a healthcare solutions company, which engages in the product manufacturing and delivery, home health supply, and perioperative services to support care through the hospital and into the home. It operates through the Products and Healthcare Services, and Patient Direct segments.